Literature DB >> 22499727

Designs combining instrumental variables with case-control: estimating principal strata causal effects.

Russell T Shinohara1, Constantine E Frangakis, Elizabeth Platz, Konstantinos Tsilidis.   

Abstract

The instrumental variables framework is commonly used for the estimation of causal effects from cohort samples. However, the combination of instrumental variables with more efficient designs such as case-control sampling requires new methodological consideration. For example, as the use of Mendelian randomization studies is increasing and the cost of genotyping and gene expression data can be high, the analysis of data gathered from more cost-effective sampling designs is of prime interest. We show that the standard instrumental variables analysis does not appropriately estimate the causal effects of interest when the instrumental variables design is combined with the case-control design. We also propose a method that can estimate the causal effects in such combined designs. We illustrate the method with a study in oncology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22499727      PMCID: PMC3608098          DOI: 10.2202/1557-4679.1355

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   0.968


  21 in total

1.  Principal stratification and attribution prohibition: good ideas taken too far.

Authors:  Marshall Joffe
Journal:  Int J Biostat       Date:  2011-09-14       Impact factor: 0.968

Review 2.  Genetic epidemiology and public health: hope, hype, and future prospects.

Authors:  George Davey Smith; Shah Ebrahim; Sarah Lewis; Anna L Hansell; Lyle J Palmer; Paul R Burton
Journal:  Lancet       Date:  2005 Oct 22-28       Impact factor: 79.321

3.  Instruments for causal inference: an epidemiologist's dream?

Authors:  Miguel A Hernán; James M Robins
Journal:  Epidemiology       Date:  2006-07       Impact factor: 4.822

4.  Polydesigns and causal inference.

Authors:  Fan Li; Constantine E Frangakis
Journal:  Biometrics       Date:  2006-06       Impact factor: 2.571

5.  C-reactive protein and its role in metabolic syndrome: mendelian randomisation study.

Authors:  Nicholas J Timpson; Debbie A Lawlor; Roger M Harbord; Tom R Gaunt; Ian N M Day; Lyle J Palmer; Andrew T Hattersley; Shah Ebrahim; Gordon D O Lowe; Ann Rumley; George Davey Smith
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

Review 6.  Mendelian randomization as an instrumental variable approach to causal inference.

Authors:  Vanessa Didelez; Nuala Sheehan
Journal:  Stat Methods Med Res       Date:  2007-08       Impact factor: 3.021

7.  Methodology for Evaluating a Partially Controlled Longitudinal Treatment Using Principal Stratification, With Application to a Needle Exchange Program.

Authors:  Constantine E Frangakis; Ronald S Brookmeyer; Ravi Varadhan; Mahboobeh Safaeian; David Vlahov; Steffanie A Strathdee
Journal:  J Am Stat Assoc       Date:  2004-03       Impact factor: 5.033

8.  Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer.

Authors:  Kristine H Allin; Stig E Bojesen; Børge G Nordestgaard
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

9.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

10.  C-reactive protein and the risk of incident colorectal cancer.

Authors:  Thomas P Erlinger; Elizabeth A Platz; Nader Rifai; Kathy J Helzlsouer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

View more
  1 in total

Review 1.  Biomarkers of Inflammation and Immune Function and Risk of Colorectal Cancer.

Authors:  Alicia Garcia-Anguita; Artemisia Kakourou; Konstantinos K Tsilidis
Journal:  Curr Colorectal Cancer Rep       Date:  2015
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.